ATTWILL Medical Solutions (AMS) operates in 3 divisions:
1. Contract Lyophilization Manufacturing: In 2017, AMS acquired the assets of Anteco Pharma, a Wisconsin-based contract manufacturer of lyophilization products. We operate a fully integrated commercialization business within a 36,500 square foot facility that includes R&D laboratories, piloting facilities and seven ISO 7 cleanrooms for manufacturing. Our ISO 13485 2016 manufacturing includes six freeze dryers that are used in contract manufacturing of products that include active drug ingredients, medical devices and nutraceuticals.
2. Vascular Technologies: We are engaged in developing innovative vascular accessory products that can improve both treatment and patient outcomes by significantly reducing the complications caused by vascular access devices.
3. Peptide Bioscience: We develop innovative biomaterials that can improve patient outcomes by significantly reducing the complications caused by vascular access device.
Our goal is to provide innovative solutions across all three divisions utilizing new technologies, new business creation, and intellectual property development.